Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve The unaudited financial results along with the limited review report of the Company for the quarter and half-year ended September 30th, 2026 and other business items, if any.

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 The Calcutta Stock Exchange Limited 7, Lyons Range, Dalhousie, Kolkata - 700001, West Bengal. Dear Sir / Madam, Ref.: Scrip Code: 543207 Sub: Intimation under Regulation 29(1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ["SEBI Listing Regulations"] We wish to inform you pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026 inter alia to consider and approve the unaudited financial results along with the limited review report of the Company for the quarter and half-year ended September 30th, 2026 and other business items, if any. Further, Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended & Company's Code of Conduct for Prevention of Insider Trading, the “Trading Window” for dealing in the equity shares of the Company is already closed, for all Designated persons of the Company from 30th September, 2026 till the expiry of 48 hours after the date of declaration of the financial results for the Quarter and half year ending 30th September, 2026. Kindly take note of the above. Thanking you, Yours faithfully, For NATURAL BIOCON (INDIA) LIMITED Sd/- Chaitali Maheshbhai Doshi Director DIN: 11930754 Date: 11.11.2026